US FDA Rare Disease Innovation Hub’s Goals Align With Trump, Leader Says

 
• By Sue Sutter
  
Cars in a row
The Rare Disease Innovation Hub is focused on driving consistency between CBER and CDER decisions. (Shutterstock)

More from Rare Diseases

More from Agency Leadership